New and Noteworthy

Showing 9 of 0 results

• Answering hematology’s hardest questions: Takeaways from a panel of RWE experts
  • Real-world evidence
  • Article
  • Blog
• Ensuring reliability of curated EHR-derived data: The Validation of Accuracy for LLM/ML-Extracted Information and Data (VALID) Framework

  JCO Cancer Clinical Informatics

  • Publication summary
  • Publications
  • Machine learning
  • Quality improvement
  • Quality reporting
• How real-world data from over 420,000 patients reveals treatment gaps in prostate and bladder cancer care
  • Real-world evidence
  • Event recap
  • Artificial intelligence
  • Blog
• From data to decisions: What “regulatory-grade” real-world evidence actually requires
  • Real-world evidence
  • Event recap
• Impact of real-world response to first-line immunotherapy and chemotherapy on subsequent treatment outcomes in patients with advanced or metastatic non-small cell lung cancer

  JCO Cancer Clinical Informatics

  • Publication summary
  • Publications
  • Treatment patterns
  • Non-small cell lung cancer
• Flatiron Health attends the 2026 American Society of Genitourinary Cancers Symposium to answer oncology's most critical questions
  • Press releases
  • Urothelial cell carcinoma
  • Prostate cancer
• Persistent gaps in BRCA mutation testing among mCRPC patients: Insights from US cancer practices (2018–2024)

  ASCO GU

  • Publication summary
  • Publications
  • Prostate cancer
• Real-world neoadjuvant therapy utilization and outcomes in patients with muscle-invasive bladder cancer ineligible for cisplatin treatment

  ASCO GU

  • Publication summary
  • Publications
  • Treatment patterns
• Beyond BRCA: Real-world outcomes with poly(ADP-ribose) polymerase inhibitors among patients with metastatic castration-resistant prostate cancer and homologous recombination repair mutations

  ASCO GU

  • Publication summary
  • Publications
  • Treatment patterns
  • Prostate cancer